Clinical Trials Logo

Clinical Trial Summary

This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated urinary tract infection (UTI)? One of the most common complications following surgery and associated with Foley catheters is post-operative urinary retention (POUR) after the catheter is removed. This is defined as being unable to urinate spontaneously within 8 hours following the removal of the indwelling Foley catheter (the catheter that sits in your bladder to drain urine after surgery). When this happens, it requires intermittent straight catheterization of the bladder (placing a temporary catheter in the bladder to drain the buildup of urine), which can cause a lot of discomfort and anxiety, as well as increase the risk of catheter-associated urinary tract infection (CAUTI).


Clinical Trial Description

All participants in this study will be males who are undergoing a planned surgery on their liver, gallbladder/biliary tract, pancreas, colon, or rectum for any reason. If able to obtain appropriate consent from a legal representative, cognitively impaired patients may be included. After having surgery where a catheter is placed in the bladder to drain urine (this is called a Foley indwelling catheter), the catheter eventually gets removed, and some of the most frequent problems that can happen after that are post-operative urinary retention (POUR) and catheter-associated urinary tract infection (CAUTI). The goal of this study is to see if a medicine called tamsulosin (also called Flomax) can decrease the rate of POUR, which means not being able to urinate spontaneously like normal, and CAUTI, which means an infection in the urinary tract. This study is important because POUR and CAUTI can cause harm to patients, including discomfort if a temporary catheter has to be placed back in the bladder to get the urine out, infection, anxiety, and stress, and it's known that these complications can also increase hospital charges. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06257576
Study type Interventional
Source Emory University
Contact Shishir K Maithel, MD
Phone 404-778-5777
Email smaithe@emory.edu
Status Recruiting
Phase Phase 3
Start date February 26, 2024
Completion date August 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06261736 - The Effectiveness of Prophylactic Antibiotics for Urethral Bulking N/A
Not yet recruiting NCT06344884 - Early Patient Removal of Urinary Catheters After Urogynecologic Surgery N/A
Recruiting NCT01309529 - Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients N/A
Recruiting NCT04444440 - Antibiotic Prophylaxis for Bladder Botox Phase 4
Completed NCT04246996 - Gentamicin Intravesical Efficacy for Infection of Urinary Tract Phase 2
Recruiting NCT03633994 - Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy Phase 2